{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T15:25:35Z","timestamp":1783005935947,"version":"3.54.5"},"reference-count":47,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI119037"],"award-info":[{"award-number":["R01 AI119037"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI147316"],"award-info":[{"award-number":["R01 AI147316"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI155765"],"award-info":[{"award-number":["R01 AI155765"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["P30 AI042853"],"award-info":[{"award-number":["P30 AI042853"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["1UL1TR001430"],"award-info":[{"award-number":["1UL1TR001430"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Adverse drug reactions (ADRs) to tuberculosis (TB) medications make treatment completion challenging. We investigated the impact of alcohol, human immunodeficiency virus (HIV), and other patient determinants on ADRs and treatment adherence.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We administered monthly ADR questionnaires to participants with TB in Worcester, South Africa. Adherence was defined as the proportion of observed doses on days when directly observed therapy was attempted. We used regression modeling to identify associations between age, sex, HIV status, alcohol, and smoked substance use with ADRs and adherence.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of 286 participants, 70 (24.5%) had moderate alcohol use (phosphatidylethanol [PEth], 20\u2013200\u2005ng\/mL), 81 (28.3%) had heavy alcohol use (PEth, &amp;gt;200\u2005ng\/mL), and 81 (28.3%) had HIV. A total of 156 (54.5%) reported \u22651 ADR, with maximum severity of moderate (75.6%) or mild (22.4%). Alcohol use and HIV were not associated with ADRs. The presence of \u22651 comorbidity compared with none was associated with a 46% increase in the risk of ADRs (P = .01). Nearly 70% of participants had \u226580% adherence. Among participants with moderate or severe ADRs, HIV with CD4 count &amp;lt;200 cells\/\u00b5L compared with no HIV (rate ratio = 1.71, P = .01), moderate or severe alcohol use compared with low (rate ratio = 1.55, P = .01 and rate ratio = 1.69, P = .01), and smoked substance use compared with none (rate ratio = 1.37, P = .04) were associated with increased missed doses.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Half of participants on TB treatment experienced ADRs, but most remained adherent to treatment. Among participants with moderate or severe ADRs, those with poorly controlled HIV, alcohol use, or smoked substance use had lower adherence.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cid\/ciae642","type":"journal-article","created":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T23:19:03Z","timestamp":1737847143000},"page":"167-175","source":"Crossref","is-referenced-by-count":3,"title":["Patient Determinants and Effects on Adherence of Adverse Drug Reactions to Tuberculosis Treatment: A Prospective Cohort Analysis"],"prefix":"10.1093","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-0810-8394","authenticated-orcid":false,"given":"Christine A","family":"Tzelios","sequence":"first","affiliation":[{"name":"Department of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0849-2348","authenticated-orcid":false,"given":"Samantha","family":"Malatesta","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Carney","sequence":"additional","affiliation":[{"name":"Mental Health, Alcohol, Substance Use & Tobacco Research Unit, South African Medical Research Council, Cape Town ,","place":["South Africa"]},{"name":"Department of Psychiatry and Mental Health, University of Cape Town, Cape Town ,","place":["South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura F","family":"White","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5828-8500","authenticated-orcid":false,"given":"Sarah E","family":"Weber","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7837-1147","authenticated-orcid":false,"given":"Sarah","family":"Thomson","sequence":"additional","affiliation":[{"name":"Section of Infectious Diseases, Boston University Chobanian and Avedisian School of Medicine and Boston Medical Center , Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danie","family":"Theron","sequence":"additional","affiliation":[{"name":"Brewelskloof Hospital , Worcester ,","place":["South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0235-6716","authenticated-orcid":false,"given":"Bronwyn","family":"Myers","sequence":"additional","affiliation":[{"name":"Mental Health, Alcohol, Substance Use & Tobacco Research Unit, South African Medical Research Council, Cape Town ,","place":["South Africa"]},{"name":"Department of Psychiatry and Mental Health, University of Cape Town, Cape Town ,","place":["South Africa"]},{"name":"Curtin enAble Institute, Faculty of Health Sciences, Curtin University, Perth ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9787-2785","authenticated-orcid":false,"given":"Charles D H","family":"Parry","sequence":"additional","affiliation":[{"name":"Mental Health, Alcohol, Substance Use & Tobacco Research Unit, South African Medical Research Council, Cape Town ,","place":["South Africa"]},{"name":"Department of Psychiatry and Mental Health, University of Cape Town, Cape Town ,","place":["South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5741-7358","authenticated-orcid":false,"given":"Robin M","family":"Warren","sequence":"additional","affiliation":[{"name":"SAMRC Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Stellenbosch University , Cape Town ,","place":["South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C Robert","family":"Horsburgh","sequence":"additional","affiliation":[{"name":"Departments of Epidemiology, Biostatistics, Global Health and Medicine, Boston University, Boston, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3871-5760","authenticated-orcid":false,"given":"Maha R","family":"Farhat","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts ,","place":["USA"]},{"name":"Department of Pulmonary and Critical Care, Massachusetts General Hospital, Boston, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4239-3685","authenticated-orcid":false,"given":"Karen R","family":"Jacobson","sequence":"additional","affiliation":[{"name":"Section of Infectious Diseases, Boston University Chobanian and Avedisian School of Medicine and Boston Medical Center , Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,2,20]]},"reference":[{"key":"2025080104322564300_ciae642-B1"},{"key":"2025080104322564300_ciae642-B2","first-page":"868","article-title":"Adverse drug reactions associated with first-line anti-tuberculosis drug regimens","volume":"11","author":"Marra","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"key":"2025080104322564300_ciae642-B3","doi-asserted-by":"crossref","first-page":"e238","DOI":"10.1371\/journal.pmed.0040238","article-title":"Patient adherence to tuberculosis treatment: a systematic review of qualitative research","volume":"4","author":"Munro","year":"2007","journal-title":"PLoS Med"},{"key":"2025080104322564300_ciae642-B4","first-page":"1","article-title":"Tuberculosis treatment non-adherence and lost to follow up among TB patients with or without HIV in developing countries: a systematic review","volume":"44","author":"Tola","year":"2015","journal-title":"Iran J Public Health"},{"key":"2025080104322564300_ciae642-B5","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1517\/14740338.5.2.231","article-title":"Adverse reactions to first-line antituberculosis drugs","volume":"5","author":"Forget","year":"2006","journal-title":"Expert Opin Drug Saf"},{"key":"2025080104322564300_ciae642-B6","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1016\/j.cegh.2015.10.005","article-title":"Prevalence of adverse drug reaction with first-line drugs among patients treated for pulmonary tuberculosis","volume":"3","author":"Singh","year":"2015","journal-title":"Clin Epidemiol Glob Health"},{"key":"2025080104322564300_ciae642-B7","doi-asserted-by":"crossref","first-page":"748310","DOI":"10.3389\/fitd.2021.748310","article-title":"Adverse drug reactions related to treatment of drug-susceptible tuberculosis in Brazil: a prospective cohort study","volume":"2:","author":"Sant\u00b4Anna","year":"2022","journal-title":"Front Trop Dis"},{"key":"2025080104322564300_ciae642-B8","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1136\/thx.2006.058867","article-title":"Adverse events and treatment interruption in tuberculosis patients with and without HIV co-infection","volume":"61","author":"Breen","year":"2006","journal-title":"Thorax"},{"key":"2025080104322564300_ciae642-B9","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/1471-2458-8-289","article-title":"Alcohol use as a risk factor for tuberculosis\u2014a systematic review","volume":"8","author":"Lonnroth","year":"2008","journal-title":"BMC Public Health"},{"key":"2025080104322564300_ciae642-B10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.5588\/ijtld.19.0080","article-title":"The impact of alcohol use on tuberculosis treatment outcomes: a systematic review and meta-analysis","volume":"24","author":"Ragan","year":"2020","journal-title":"Int J Tuberc Lung Dis"},{"key":"2025080104322564300_ciae642-B11","doi-asserted-by":"crossref","first-page":"e02167-19","DOI":"10.1128\/AAC.02167-19","article-title":"Fact versus fiction: a review of the evidence behind alcohol and antibiotic interactions","volume":"64","author":"Mergenhagen","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"2025080104322564300_ciae642-B12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/14740338.2020.1694901","article-title":"Safety implications of combined antiretroviral and anti-tuberculosis drugs","volume":"19","author":"Cerrone","year":"2020","journal-title":"Expert Opin Drug Saf"},{"key":"2025080104322564300_ciae642-B13","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12981-016-0106-y","article-title":"Integrated therapy for HIV and tuberculosis","volume":"13","author":"Manosuthi","year":"2016","journal-title":"AIDS Res Ther"},{"key":"2025080104322564300_ciae642-B14","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1186\/1471-2458-10-651","article-title":"Barriers and facilitators of adherence to TB treatment in patients on concomitant TB and HIV treatment: a qualitative study","volume":"10","author":"Gebremariam","year":"2010","journal-title":"BMC Public Health"},{"key":"2025080104322564300_ciae642-B15","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/S1473-3099(22)00149-9","article-title":"Prevalence of bacteriologically confirmed pulmonary tuberculosis in South Africa, 2017\u201319: a multistage, cluster-based, cross-sectional survey","volume":"22","author":"Moyo","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"2025080104322564300_ciae642-B16","doi-asserted-by":"crossref","first-page":"10678","DOI":"10.3390\/ijerph182010678","article-title":"Tuberculosis treatment outcome and predictors in Africa: a systematic review and meta-analysis","volume":"18","author":"Teferi","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"2025080104322564300_ciae642-B17","volume-title":"Global status report on alcohol and health 2018","year":"2019"},{"key":"2025080104322564300_ciae642-B18","doi-asserted-by":"crossref","first-page":"1700216","DOI":"10.1183\/13993003.00216-2017","article-title":"Alcohol consumption as a risk factor for tuberculosis: meta-analyses and burden of disease","volume":"50","author":"Imtiaz","year":"2017","journal-title":"Eur Respir J"},{"key":"2025080104322564300_ciae642-B19"},{"key":"2025080104322564300_ciae642-B20","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1186\/s12879-018-3396-y","article-title":"Impact of alcohol consumption on tuberculosis treatment outcomes: a prospective longitudinal cohort study protocol","volume":"18","author":"Myers","year":"2018","journal-title":"BMC Infect Dis"},{"key":"2025080104322564300_ciae642-B21","author":"Western Cape Government"},{"key":"2025080104322564300_ciae642-B22","author":"UNAIDS"},{"key":"2025080104322564300_ciae642-B23","author":"South Africa District HIV Estimates"},{"key":"2025080104322564300_ciae642-B24","first-page":"65","article-title":"Comparison of baseline drinking practices, knowledge, and attitudes of adults residing in communities taking part in the FAS prevention study in South Africa","volume":"11","author":"Parry","year":"2012","journal-title":"Afr J Drug Alcohol Stud"},{"key":"2025080104322564300_ciae642-B25"},{"key":"2025080104322564300_ciae642-B26","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/alcalc\/agl027","article-title":"Phosphatidylethanol (PEth) concentrations in blood are correlated to reported alcohol intake in alcohol-dependent patients","volume":"41","author":"Aradottir","year":"2006","journal-title":"Alcohol Alcohol"},{"key":"2025080104322564300_ciae642-B27","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/acer.15062","article-title":"Self-reported alcohol use versus phosphatidylethanol in behavioral trials: a study of people living with HIV in Tshwane, South Africa","volume":"47","author":"Parry","year":"2023","journal-title":"Alcohol Clin Exp Res (Hoboken)"},{"key":"2025080104322564300_ciae642-B28","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jsat.2015.01.008","article-title":"The psychometric properties of the Drug Use Disorders Identification Test (DUDIT): a review of recent research","volume":"53","author":"Hildebrand","year":"2015","journal-title":"J Subst Abuse Treat"},{"key":"2025080104322564300_ciae642-B29","doi-asserted-by":"crossref","first-page":"e24510","DOI":"10.2196\/24510","article-title":"Directly observed therapy to measure adherence to tuberculosis medication in observational research: protocol for a prospective cohort study","volume":"10","author":"Ragan","year":"2021","journal-title":"JMIR Res Protoc"},{"key":"2025080104322564300_ciae642-B30","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/aje\/kwh090","article-title":"A modified Poisson regression approach to prospective studies with binary data","volume":"159","author":"Zou","year":"2004","journal-title":"Am J Epidemiol"},{"key":"2025080104322564300_ciae642-B31","author":"R Core Team"},{"key":"2025080104322564300_ciae642-B32","author":"Chongsuvivatwong V"},{"key":"2025080104322564300_ciae642-B33","doi-asserted-by":"crossref","DOI":"10.1007\/978-0-387-21706-2","volume-title":"Modern applied statistics with S","author":"Venables","year":"2002","edition":"4th ed"},{"key":"2025080104322564300_ciae642-B34","volume-title":"Livertox: clinical and research information on drug-induced liver injury","author":"Isoniazid","year":"2012"},{"key":"2025080104322564300_ciae642-B35","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s11096-010-9452-3","article-title":"Convergence of tuberculosis and diabetes mellitus: time to individualise pharmaceutical care","volume":"33","author":"Gnanasan","year":"2011","journal-title":"Int J Clin Pharm"},{"key":"2025080104322564300_ciae642-B36","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s11908-015-0464-y","article-title":"Cutaneous manifestations of human immunodeficiency virus: a clinical update","volume":"17","author":"Altman","year":"2015","journal-title":"Curr Infect Dis Rep"},{"key":"2025080104322564300_ciae642-B37","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jaad.2010.01.061","article-title":"Cutaneous toxicities of antiretroviral therapy for HIV: part I. Lipodystrophy syndrome, nucleoside reverse transcriptase inhibitors, and protease inhibitors","volume":"63","author":"Introcaso","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"2025080104322564300_ciae642-B38","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1093\/cid\/ciz732","article-title":"High rates of drug-induced liver injury in people living with HIV coinfected with tuberculosis (TB) irrespective of antiretroviral therapy timing during antituberculosis treatment: results from the Starting Antiretroviral Therapy at Three Points in TB Trial","volume":"70","author":"Naidoo","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2025080104322564300_ciae642-B39","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1186\/1471-2458-13-396","article-title":"Predictors of tuberculosis (TB) and antiretroviral (ARV) medication non-adherence in public primary care patients in South Africa: a cross sectional study","volume":"13","author":"Naidoo","year":"2013","journal-title":"BMC Public Health"},{"key":"2025080104322564300_ciae642-B40","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/QAI.0b013e3181b18b6e","article-title":"Alcohol use and antiretroviral adherence: review and meta-analysis","volume":"52","author":"Hendershot","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2025080104322564300_ciae642-B41","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.drugalcdep.2015.12.013","article-title":"Binge drinking is associated with differences in weekday and weekend adherence in HIV-infected individuals","volume":"159","author":"De Boni","year":"2016","journal-title":"Drug Alcohol Depend"},{"key":"2025080104322564300_ciae642-B42","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1186\/s12889-024-19570-y","article-title":"Patient and provider perceptions of the relationship between alcohol use and TB and readiness for treatment: a qualitative study in South Africa","volume":"24","author":"Kulkarni","year":"2024","journal-title":"BMC Public Health"},{"key":"2025080104322564300_ciae642-B43","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1056\/NEJMoa2212537","article-title":"Treatment strategy for rifampin-susceptible tuberculosis","volume":"388","author":"Paton","year":"2023","journal-title":"N Engl J Med"},{"key":"2025080104322564300_ciae642-B44","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1056\/NEJMoa2033400","article-title":"Four-month rifapentine regimens with or without moxifloxacin for tuberculosis","volume":"384","author":"Dorman","year":"2021","journal-title":"N Engl J Med"},{"key":"2025080104322564300_ciae642-B45","doi-asserted-by":"crossref","first-page":"ofae178","DOI":"10.1093\/ofid\/ofae178","article-title":"Experience with four-month rifapentine and moxifloxacin-based tuberculosis treatment in San Francisco","volume":"11","author":"Louie","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"2025080104322564300_ciae642-B46","doi-asserted-by":"crossref","first-page":"891","DOI":"10.5588\/ijtld.11.0795","article-title":"Alcohol use and the management of multidrug-resistant tuberculosis in Tomsk, Russian Federation","volume":"16","author":"Miller","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"2025080104322564300_ciae642-B47","doi-asserted-by":"crossref","first-page":"e0147744","DOI":"10.1371\/journal.pone.0147744","article-title":"Impact of community-based DOT on tuberculosis treatment outcomes: a systematic review and meta-analysis","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS One"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciae642\/62008253\/ciae642.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/81\/1\/167\/62008253\/ciae642.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/81\/1\/167\/62008253\/ciae642.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T08:33:34Z","timestamp":1754037214000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/81\/1\/167\/8026185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,20]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,2,20]]},"published-print":{"date-parts":[[2025,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciae642","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,7,15]]},"published":{"date-parts":[[2025,2,20]]}}}